Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1245, pseudogene (RNU6-1245P) is a human gene classified as a pseudogene; it is not translated into a functional protein and is thought to result from duplication or mutation of a functional U6 small nuclear RNA gene[5][1][7][3][8]. U6 small nuclear RNA pseudogenes may play roles in gene regulation in rare contexts (e.g., acting as miRNA decoys or competing for RNA-binding proteins), but there is no established function, disease association, or therapeutic role for RNU6-1245P itself[5][2]. It is cataloged in major genetic and genomic databases for reference and annotation but is not recognized as a therapeutic target, receptor, or enzymatic entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1245, pseudogene (RNU6-1245P).